Previous close | 1.3700 |
Open | 1.3800 |
Bid | 1.3200 x 1800 |
Ask | 1.3500 x 900 |
Day's range | 1.3300 - 1.4500 |
52-week range | 0.3600 - 1.9200 |
Volume | |
Avg. volume | 2,530,942 |
Market cap | 194.691M |
Beta (5Y monthly) | -0.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 28 Apr 2014 |
1y target est | N/A |
Explore key insights from Veru Inc's Q2 2024 earnings, emphasizing improved financial management and strategic advancements in pharmaceutical development.
Veru's Innovative Clinical Programs Progress as Financial Challenges Persist
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?